Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Antiandrogens don't help with COVID-19 and aren't recommended.

Flutamide rarely causes liver toxicity in prostate cancer patients.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Minoxidil decreases LH expression, while hydralazine has mixed effects on prolyl and lysyl hydroxylase activities.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

New compounds were made that are promising for prostate cancer therapy.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.